Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Jean-Yves Blay

Jean-Yves Blay


Centre Léon Bérard

Professor Jean-Yves Blay has been Director of the Centre Léon Bérard, the comprehensive cancer centre of Lyon and the Rhône-Alpes region, since December 2014. He is also an oncologist, a researcher and a medical oncologist professor at the University Claude Bernard Lyon1, and a corresponding member of the French Academy of Medicine.

Professor Blay has been President of the European Organization for Research and Treatment of Cancer (EORTC) from 2009 to 2012. Currently President of the  French  Sarcoma  Group / GETO, he is the network leader of the NETSARC network of reference centres for sarcoma treatment certified by the French National Cancer Institute, the former PI of Conticanet (a FP6 network of excellence), and the current PI of the FP7 project EuroSARC. He is the director of the Integrated Centre for innovation on Cancer Research of Lyon (LYRIC).

Professor Blay is the director of the ERN-EURACAN, designated in December 2016 by the European Commission, to improve the quality of care for patients with rare cancers in the European Union.

Professor Blay is an active member of the European Society for Medical Oncology, the American Society of Clinical Oncology, the American Association of Cancer Research and has served as member of Scientific Committees for the ESMO and AACR meetings. He has been a reviewer for the Journal of Clinical Oncology, Blood, Cancer, Annals of Oncology and the European Journal of Cancer, among others.

He has received awards such as the Hamilton Fairley Award in 2012 from ESMO and the Henry and Mary-Jane Mitjavile prize in 2013 from the National Academy of Medicine.

His research interests focus on clinical and basic research in sarcomas, targeted treatment of cancer, the biology of breast carcinoma and the relationship between tumour immunologic microenvironment and malignant cells with the goal of clinical applications in the fields of diagnosis, prognosis and treatment. Professor Blay has authored over 550 peer-reviewed articles.

Professor Blay has been the Sarcoma & GIST subject editor for the ESMO Guidelines Committee since 2015, and a member of the ESMO Open Editorial Board since 2016.

Professor Blay has also been a member of the ESMO EU Policy Committee since 2012, and of the ESMO Principles of Clinical Trials and Systemic Therapy Faculty since 2015.

He was also a coordinator for the ESMO Sarcoma Faculty, 2012-2016, and a member since 2017. Furthermore, he was a member of the ESMO Educational Committee, 2012-2016. 

ESMO 2017 Congress

"The Sarcoma Track will be an opportunity to discuss the evolving guidelines and major changes in the organisation of sarcoma patient management, and to discover major new research results in the field of sarcoma."

Jean-Yves Blay


Jean-Yves Blay was the Sarcoma Track Chair of the ESMO 2017 Congress, which took place in Madrid, Spain (8-12 September 2017).

View ESMO 2017 Congress meeting resources

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings